Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

China Universal Asset Management Co. Ltd. boosted its holdings in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by ...

Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...

With the stock market overbought and insiders selling, shares of these five outstanding large-cap companies look like just ...

SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on ...

A Bank of America branch was one of several businesses ... for 20-years that God 'would put me in a position' to end chronic disease I'm a heart surgeon. These are 6 things I avoid for my own ...

Bank of America chose Teva Pharmaceutical Industries ... treatment for schizophrenia and Duvakitug for inflammatory bowel disease, which is entering Phase 3." Bank of America listed several ...

BofA Securities has a Buy rating with a $95 ... Cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and ...

In a report released today, Jason Zemansky from Bank of America Securities maintained ... options for rare and devastating pediatric diseases. Its multi-platform development approach applies ...

Heartflow, Bain Capital, BofA and JPMorgan all declined to comment ... device that can be used to diagnose coronary artery disease, which affects about 16mn Americans, according to official ...

In addition, Bank of America downgraded the stock on worries ... demand after the U.S. reported the first human death from the disease. Shares of Getty Images Holdings (GETY) and Shutterstock ...